• FITC-Concanavalin A (ConA) Conjugate: Technical Workflow Gui

  2026-07-23

  FITC-Concanavalin A (ConA) Conjugate is designed for direct, fluorescent detection of α-D-glucose and α-D-mannose moieties on cell surfaces, enabling researchers to analyze glycan distribution via immunofluorescence or flow cytometry. This fluorescent lectin conjugate is not suitable for non-carbohydrate targets or for use outside its defined storage and stability conditions. It is best applied in workflows requiring specific cell surface carbohydrate detection.

• AMPK–SQSTM1 Feedback Loop Synergizes Antioxidant Defense in

  2026-07-23

  This study uncovers a double-positive feedback loop between AMPK and SQSTM1/p62 in cancer cells under metabolic stress, leading to the dual activation of AMPK and NFE2L2/NRF2 and enhanced antioxidant responses. These findings clarify the molecular adaptations underlying co-occurring STK11 and KEAP1 mutations in non-small cell lung cancer and suggest new avenues for targeted therapeutic strategies.

• PERK–JAK1–STAT3 Pathway Links ER Stress to Pyroptosis in Dis

  2026-07-22

  This study establishes how unresolved endoplasmic reticulum stress (ERS) induces pyroptosis and inflammation in nucleus pulposus cells through a PERK-driven JAK1–STAT3 signaling cascade. These mechanistic insights reveal new molecular targets for mitigating intervertebral disc degeneration and highlight the value of selective ER stress blockers in disease modeling.

• Spirocyclic POM Analogues Target MmpL3 in Drug-Resistant Tub

  2026-07-22

  This study reports the design and synthesis of spirocyclic phenyl oxazole methyl (POM) analogues as potent inhibitors of Mycobacterium tuberculosis, specifically targeting the essential transporter MmpL3. The findings highlight compound 5c’s strong activity against drug-resistant clinical isolates and underscore the promise of this new chemical class for anti-tubercular drug development.

• Trichostatin A (TSA): Epigenetic Modulation Beyond Oncology

  2026-07-21

  Explore the advanced epigenetic functions of Trichostatin A (TSA) in both cancer and immune cell biology. This article delivers in-depth scientific insight and protocol guidance, setting it apart from typical TSA overviews.

• Resazurin Cell Viability Assay Kit: Precision in Proliferati

  2026-07-21

  The Resazurin Cell Viability Assay Kit empowers researchers with ultra-sensitive, non-toxic quantification of live cells across animal, plant, and microbial systems. Its ready-to-use format and dual-mode readout streamline high-throughput workflows, while advanced troubleshooting tips ensure reproducibility and accuracy in even the most demanding experimental settings.

• Tobramycin: Applied Workflows for Gram-Negative Antibiotic R

  2026-07-20

  Tobramycin, a water-soluble aminoglycoside antibiotic, empowers researchers to dissect Gram-negative resistance mechanisms and optimize antibacterial assays. With evidence-backed workflows and troubleshooting insights, this guide translates bench research into reproducible outcomes for antibiotic discovery.

• Cinoxacin in UTI Research: Quinolone Antibiotic Workflows &

  2026-07-20

  Cinoxacin stands out as a rigorously characterized quinolone antibiotic for urinary tract infection and Gram-negative resistance research. This guide delivers actionable workflows and troubleshooting insights, spotlighting Cinoxacin’s protocol flexibility and reproducibility for advanced experimental models.

• Difloxacin HCl: Quinolone Antimicrobial and MDR Reversal Age

  2026-07-19

  Difloxacin HCl is a quinolone antimicrobial antibiotic with validated roles in bacterial DNA gyrase inhibition and multidrug resistance (MDR) reversal. It supports both precise antimicrobial susceptibility testing and research into overcoming MDR in oncology settings.

• In Vitro Activity of Temafloxacin vs. Gram-Negative Bacteria

  2026-07-18

  This article examines the in vitro efficacy of temafloxacin, a fluoroquinolone antibiotic, against a wide range of gram-negative bacterial pathogens. The findings highlight temafloxacin's improved potency and broader activity spectrum compared to older quinolones, with implications for future urinary tract infection and antibiotic resistance research.

• Bafilomycin C1 as a Vacuolar H+-ATPases Inhibitor in Autopha

  2026-07-17

  Bafilomycin C1 empowers researchers to dissect lysosomal and autophagic processes with unmatched specificity, streamlining advanced workflows from iPSC-based cardiotoxicity screens to high-fidelity apoptosis research. This article translates deep-learning-enabled discoveries into practical laboratory strategies, emphasizing protocol precision, troubleshooting, and the unique strengths of APExBIO’s Bafilomycin C1.

• KPT-330 (Selinexor): Applied Workflows for Nuclear Export In

  2026-07-17

  KPT-330 (Selinexor) uniquely enables targeted apoptosis induction and tumor suppression in cancer models by selectively inhibiting CRM1-mediated nuclear export. This guide translates the latest reference findings into practical, optimized protocols and advanced troubleshooting tips for translational oncology research.

• BAY-826: Potent Small Molecule Inhibitor for Retinal Researc

  2026-07-16

  BAY-826 is a potent small molecule inhibitor targeting angiopoietin signaling pathways relevant to angiogenesis and retinal neuron survival. It offers nanomolar potency and selectivity, enabling precise modulation in neurovascular research applications.

• Estradiol, ER-α, and ER Stress: CD4+ T Cell Recovery Post-Sh

  2026-07-16

  This study demonstrates that 17β-estradiol restores the proliferation and cytokine production of splenic CD4+ T lymphocytes after hemorrhagic shock by inhibiting endoplasmic reticulum stress (ERS) through estrogen receptor-α (ER-α) and GPR30, but not ER-β. These findings clarify the immunomodulatory roles of estrogen signaling and highlight mechanistic checkpoints for addressing immune dysfunction after trauma.

• Intra- and Extracellular Dicloxacillin Activity Against MSSA

  2026-07-15

  This study rigorously characterizes the intra- and extracellular efficacy of dicloxacillin against methicillin-sensitive Staphylococcus aureus (MSSA) using both in vitro macrophage models and in vivo murine peritonitis. The findings clarify the relationship between pharmacokinetics, pharmacodynamics, and antibiotic activity, providing a robust foundation for optimizing experimental models in Gram-positive bacterial infection research.

16396 records 1/1094 page Next 12345 下5页 Last page